news

Vivani Medical, Inc. Announces Pricing of Common Stock Offering

October 26, 2025 19:15 ET  | Source: Vivani Medical, Inc. ALAMEDA, Calif., Oct. 26, 2025 (GLOBE NEWSWIRE) -- Vivani Medical,…

6 months ago

Indigenously Designed and Manufactured Laptops by Vyonix Launched at IMC 2025

GURUGRAM, India, Oct. 27, 2025 /PRNewswire/ -- India's 1st indigenously designed and manufactured Laptops, were launched at the India Mobile…

6 months ago

Xinhua Silk Road: China’s Langjiu holds “Chinese Langjiu, Welcoming the World” event in Italy

BEIJING, Oct. 27, 2025 /PRNewswire/ -- Langjiu, a leading Chinese baijiu brand, has held the "Chinese Langjiu, Welcoming the World"…

6 months ago

Credit Blockchain Brings AI Computing to the Forefront, Targeting Stability Amid Crypto Turbulence

London, Oct. 26, 2025 (GLOBE NEWSWIRE) -- Credit Blockchain, a global leader in decentralised finance infrastructure and intelligent digital computing,…

6 months ago

Hohem Lands in Best Buy Stores with AI Gimbals

NEW YORK, Oct. 26, 2025 (GLOBE NEWSWIRE) -- Hohem, a global leader in Al gimbals, is officially launching its top…

6 months ago

New Crypto Mutuum Finance (MUTM) Announces V1 Protocol as Investor Count Tops 17,400

Dubai, UAE, Oct. 26, 2025 (GLOBE NEWSWIRE) -- Ethereum remains at the heart of decentralized finance (DeFi), powering hundreds of…

6 months ago

Avacta presents first preclinical data from dual payload pre|CISION medicines at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets

First-in-class dual payload peptide drug conjugate delivers two complementary therapies from a single molecule with potential to overcome resistance and…

6 months ago

Preclinical Data Presented at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Support Potential of BBO-10203, a First-in-Class RAS:PI3K Breaker That Inhibits KRAS-Mutant Tumor Growth without Inducing Hyperglyc

Data demonstrate BBO-10203 blocks RAS-mediated activation of PI3Kα and strongly inhibits pAKT signaling in tumor cells without affecting glucose metabolismRobust…

6 months ago

Cullinan Therapeutics Shares Additional Preclinical B Cell Depletion Data for CLN-978, Supporting Clinical Development Across Multiple Autoimmune Diseases, at ACR Convergence 2025

October 25, 2025 11:01 ET  | Source: Cullinan Therapeutics, Inc. CLN-978 led to rapid and deep B cell depletion in…

6 months ago

CGTN: Restoring the History of Taiwan

BEIJING, Oct. 25, 2025 /PRNewswire/ -- Men forget, and history overlooks. But history is not, and must not become, a…

6 months ago